Exosomes Market Size, Share and Trends Analysis Report By Workflow (Isolation, Downstream Analysis), By Biomolecule Type (Non-coding RNA, mRNA, Protein, Lipid), By Application, And Segment Forecasts, 2014 - 2030

Published: Jan, 2018 | Pages: 150 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)

The global exosomes market size is expected to reach USD 2.28 billion by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 18.8% during the forecast period. Nanovesicles, which play a major role in intercellular communication, are anticipated to witness a significant rise in R&D, thus leading to revenue growth in the coming years. 

Application of these vesicles as carriers of functional content such as circulating nucleic acids, lipids, and proteins can be attributed to market growth. In addition, exosomes play an important role in immunosurveillance and tumor pathogenesis. Increasing research programs focusing on determining the role of exosomes in hepatocellular carcinoma (HCC) is estimated to drive the market.

Rising number of articles pertaining to exosomal research is encouraging R&D activities in the field. Currently, there are more than 4400 articles published about exosomes, with approximately 25% of these published in 2016 alone. In addition to the exponential rise in article publication, number of companies engaged in the research is also increasing.

These companies are taking advantage of the natural propensity of exosomes for the transmission of macromolecule payloads between cells. Application of these molecules in research activities related to therapeutics and diagnostics is projected to result in exponential growth in the coming years.

Moreover, increase in funding for R&D in this field is poised to positively influence industrial growth. Rise in funding capacity by public and private institutions is indicative of the importance of exRNA molecules across the community engaged in translational research pertaining to diagnostics and therapeutic product development.

Further key findings from the report suggest:

• By workflow, downstream analysis will account for a little over half the market revenue in 2030, due to rising advancements in methods and instruments

• Ultracentrifugation represented the leading share in the isolation methods segment owing to higher adoption of technology as compared to other methods of isolation. Immunocapture on beads is anticipated to witness the fastest growth over the forecast period due to advancements in lab-on-a-chip techniques

• In 2016, cancer was the leading application segment with a valuation of USD 1.15 million. Increasing penetration of companies in oncology-based research on biomarker identification is contributing to the growth of the segment

• North America commanded the dominant share in terms of market revenue due to presence of a large number of academic and private organizations engaged in the launch of novel technologies

• Major participants operating in this sector include Takara Bio Company; Illumina, Inc.; Thermo Fisher Scientific, Inc.; Fujifilm; and Qiagen. Strategies adopted by these participants include patent filing, inauguration of certified production facility, and launch of novel instruments.

 Table of Contents

Chapter 1 Research Methodology
                  1.1 Information procurement
                  1.2 Information or Data Analysis
                  1.3 Market Formulation & Validation

Chapter 2 Executive Summary
                  2.1 Market Snapshot

Chapter 3 Exosomes Market: Variables, Trends & Scope
                  3.1 Market segmentation & scope
                      3.1.1 Market Driver Analysis
                          3.1.1.1 Technological advancements in exosomes isolation and analytical procedures
                          3.1.1.2 Advanced applications of exosomes
                          3.1.1.3 Growth in government and non-government initiatives for exosome research
                          3.1.1.4 Increasing prevalence of cancer
                      3.1.2 Market Restraint Analysis
                          3.1.2.1 Stringent regulations pertaining to approval
                          3.1.2.2 Challenges associated with implementation
                  3.2 Penetration & Growth Prospect Mapping for Biomolecule Type, 2016
                  3.3 Exosomes - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
                  3.4 Industry Analysis - Porter's

Chapter 4 Exosomes Market: Workflow Estimates & Trend Analysis
                  4.1 Exosomes Market: Workflow Movement Analysis
                  4.2 Isolation Methods
                      4.2.1 Global isolation methods market, 2014 - 2030 (USD Million)
                      4.2.2 Ultracentrifugation
                          4.2.2.1 Global ultracentrifugation market, 2014 - 2030 (USD Million)
                      4.2.3 Immunocapture on Beads
                          4.2.3.1 Global immunocapture on beads market, 2014 - 2030 (USD Million)
                      4.2.4 Precipitation
                          4.2.4.1 Global precipitation market, 2014 - 2030 (USD Million)
                      4.2.5 Filtration
                          4.2.5.1 Global filtration market, 2014 - 2030 (USD Million)
                  4.3 Downstream Analysis
                      4.3.1 Global downstream analysis market, 2014 - 2030 (USD Million)
                      4.3.2 Cell surface marker analysis using flow cytometry
                          4.3.2.1 Global cell surface marker analysis using flow cytometry market, 2014 - 2030 (USD Million)
                      4.3.3 Protein analysis using blotting & ELISA
                          4.3.3.1 Global protein analysis using blotting & ELISA market, 2014 - 2030 (USD Million)
                      4.3.4 RNA Analysis with NGS & PCR
                          4.3.4.1 Global RNA analysis with NGS & PCR market, 2014 - 2030 (USD Million)
                      4.3.5 Proteomic Analysis using Mass Spectrometry
                          4.3.5.1 Global proteomic analysis using mass spectrometry market, 2014 - 2030 (USD Million)
                      4.3.6 Others
                          4.3.6.1 Global other methods market, 2014 - 2030 (USD Million)

Chapter 5 Exosomes Market: Biomolecule Type Estimates & Trend Analysis
                  5.1 Exosomes Market: Biomolecule Type Movement Analysis
                  5.2 Non-coding RNAs
                      5.2.1 Global non-coding RNAs market, 2014 - 2030 (USD Million)
                  5.3 mRNA (exoRNA)
                      5.3.1 Global mRNA (exoRNA) market, 2014 - 2030 (USD Million)
                  5.4 Proteins /peptides
                      5.4.1 Global proteins/peptides market, 2014 - 2030 (USD Million)
                  5.5 DNA fragments (exosomal DNA, exoDNA)
                      5.5.1 Global DNA fragments (exosomal DNA, exoDNA) market, 2014 - 2030 (USD Million)
                  5.6 Lipids
                      5.6.1 Global lipids market, 2014 - 2030 (USD Million)

Chapter 6 Exosomes Market: Application Estimates & Trend Analysis
                  6.1 Exosomes Market: Application Movement Analysis
                  6.2 Cancer
                      6.2.1 Global cancer market, 2014 - 2030 (USD Million)
                  6.3 Neurodegenerative diseases
                      6.3.1 Global neurodegenerative diseases market, 2014 - 2030 (USD Million)
                  6.4 Cardiovascular diseases
                      6.4.1 Global cardiovascular diseases market, 2014 - 2030 (USD Million)
                  6.5 Infectious diseases
                      6.5.1 Global infectious diseases market, 2014 - 2030 (USD Million)
                  6.6 Others
                      6.6.1 Global others market, 2014 - 2030 (USD Million)

Chapter 7 Exosomes Market: Regional Estimates & Trend Analysis, by Workflow, Biomolecule Type & Application
                  7.1 Exosomes market share by region, 2016 & 2030
                  7.2 North America
                      7.2.1 North America exosomes market, 2014 - 2030 (USD Million)
                      7.2.2 U.S.
                          7.2.2.1 U.S. exosomes market, by workflow, 2014 - 2030 (USD Million)
                          7.2.2.2 U.S. exosomes market, by biomolecule type, 2014 - 2030 (USD Million)
                          7.2.2.3 U.S. exosomes market, by application, 2014 - 2030 (USD Million)
                      7.2.3 Canada
                          7.2.3.1 Canada exosomes market, by workflow, 2014 - 2030 (USD Million)
                          7.2.3.2 Canada exosomes market, by biomolecule type, 2014 - 2030 (USD Million)
                          7.2.3.3 Canada exosomes market, by application, 2014 - 2030 (USD Million)
                  7.3 Europe
                      7.3.1 Europe exosomes market, 2014 - 2030 (USD Million)
                      7.3.2 Germany
                          7.3.2.1 Germany exosomes market, by workflow, 2014 - 2030 (USD Million)
                          7.3.2.2 Germany exosomes market, by biomolecule type, 2014 - 2030 (USD Million)
                          7.3.3.3 Germany exosomes market, by application, 2014 - 2030 (USD Million)
                      7.3.3 U.K.
                          7.3.3.1 U.K. exosomes market, by workflow, 2014 - 2030 (USD Million)
                          7.3.3.2 U.K. exosomes market, by biomolecule type, 2014 - 2030 (USD Million)
                          7.3.3.3 U.K. exosomes market, by application, 2014 - 2030 (USD Million)
                  7.4 Asia Pacific
                      7.4.1 Asia Pacific exosomes market, 2014 - 2030 (USD Thousand)
                      7.4.2 Japan
                          7.4.2.1 Japan exosomes market, by workflow, 2014 - 2030 (USD Million)
                          7.4.2.2 Japan exosomes market, by biomolecule type, 2014 - 2030 (USD Million)
                          7.4.2.3 Japan exosomes market, by application, 2014 - 2030 (USD Million)
                      7.4.3 China
                          7.4.3.1 China exosomes market, by workflow, 2014 - 2030 (USD Million)
                          7.4.3.2 China exosomes market, by biomolecule type, 2014 - 2030 (USD Million)
                          7.4.3.3 China exosomes market, by application, 2014 - 2030 (USD Million)
                  7.5 Latin America
                      7.5.1 Latin America exosomes market, 2014 - 2030 (USD Thousand)
                      7.5.2 Brazil
                          7.5.2.1 Brazil exosomes market, by workflow, 2014 - 2030 (USD Million)
                          7.5.2.2 Brazil exosomes market, by biomolecule type, 2014 - 2030 (USD Million)
                          7.5.2.3 Brazil exosomes market, by application, 2014 - 2030 (USD Million)
                  7.6 Middle East & Africa
                      7.6.1 Middle East & Africa exosomes market, 2014 - 2030 (USD Thousand)
                      7.6.2 South Africa
                          7.6.2.1 South Africa exosomes market, by workflow, 2014 - 2030 (USD Million)
                          7.6.2.2 South Africa exosomes market, by biomolecule type, 2014 - 2030 (USD Million)
                          7.6.2.3 South Africa exosomes market, by application, 2014 - 2030 (USD Million)

Chapter 8 Competitive Landscape
                  8.1 Strategy framework
                  8.2 Market participation categorization
                  8.3 Company Profiles
                      8.3.1 Fujifilm
                          8.3.1.1 Company Overview
                          8.3.1.2 Financial Performance
                          8.3.1.3 Product Benchmarking
                          8.3.1.4 Strategic Initiatives
                      8.3.2 Danaher
                          8.3.2.1 Company Overview
                          8.3.2.2 Financial Performance
                          8.3.2.3 Product Benchmarking
                          8.3.2.4 Strategic Initiatives
                      8.3.3 Lonza
                          8.3.3.1 Company Overview
                          8.3.3.2 Financial Performance
                          8.3.3.3 Product Benchmarking
                          8.3.3.4 Strategic Initiatives
                      8.3.4 Illumina, Inc.
                          8.3.4.1 Company Overview
                          8.3.4.2 Financial Performance
                          8.3.4.3 Product Benchmarking
                          8.3.4.4 Strategic Initiatives
                      8.3.5 Thermo Fisher Scientific, Inc.
                          8.3.5.1 Company Overview
                          8.3.5.2 Financial Performance
                          8.3.5.3 Product Benchmarking
                          8.3.5.4 Strategic Initiatives
                      8.3.6 Qiagen
                          8.3.6.1 Company Overview
                          8.3.6.2 Financial Performance
                          8.3.6.3 Product Benchmarking
                          8.3.6.4 Strategic Initiatives
                      8.3.7 Takara Bio Company
                          8.3.7.1 Company Overview
                          8.3.7.2 Financial Performance
                          8.3.7.3 Product Benchmarking
                          8.3.7.4 Strategic Initiatives
                      8.3.8 Malvern Instruments Ltd.
                          8.3.8.1 Company Overview
                          8.3.8.2 Financial Performance
                          8.3.8.3 Product Benchmarking
                          8.3.8.4 Strategic Initiatives
                      8.3.9 Hitachi Chemical Diagnostics, Inc.
                          8.3.9.1 Company Overview
                          8.3.9.2 Financial Performance
                          8.3.9.3 Product Benchmarking
                          8.3.9.4 Strategic Initiatives
                      8.3.10 Miltenyi Biotec
                          8.3.10.1 Company Overview
                          8.3.10.2 Financial Performance
                          8.3.10.3 Product Benchmarking
                          8.3.10.4 Strategic Initiatives
                      8.3.11 Diagenode
                          8.3.11.1 Company Overview
                          8.3.11.2 Financial Performance
                          8.3.11.3 Product Benchmarking
                          8.3.11.4 Strategic Initiatives
                      8.3.12 Novus Biologicals
                          8.3.12.1 Company Overview
                          8.3.12.2 Financial Performance
                          8.3.12.3 Product Benchmarking
                          8.3.12.4 Strategic Initiatives
                      8.3.13 New England Peptide, Inc.
                          8.3.13.1 Company Overview
                          8.3.13.2 Financial Performance
                          8.3.13.3 Product Benchmarking
                          8.3.13.4 Strategic Initiatives
                      8.3.14 BioVision Inc
                          8.3.14.1 Company Overview
                          8.3.14.2 Financial Performance
                          8.3.14.3 Product Benchmarking
                          8.3.14.4 Strategic Initiatives
                      8.3.15 MBL International Corporation
                          8.3.15.1 Company Overview
                          8.3.15.2 Financial Performance
                          8.3.15.3 Product Benchmarking
                          8.3.15.4 Strategic Initiatives
                      8.3.16 BioCat GmbH
                          8.3.16.1 Company Overview
                          8.3.16.2 Financial Performance
                          8.3.16.3 Product Benchmarking
                          8.3.16.4 Strategic Initiatives

List of Tables

TABLE 1 Global cancer incidences, 2012
TABLE 2 North America cancer incidences in 2012
TABLE 3 Europe cancer incidences, 2012
TABLE 4 Asia cancer incidences, 2012
TABLE 5 Africa cancer incidences, 2012
TABLE 6 Australia and New Zealand cancer incidences in 2012
TABLE 7 North America exosomes market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 8 North America isolation methods market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 9 North America downstream analysis market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 10 North America exosomes market estimates & forecasts, by biomolecule type, 2014 - 2030 (USD Million)
TABLE 11 North America exosomes market estimates & forecasts, by application, 2014 - 2030 (USD Million)
TABLE 12 U.S. exosomes market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 13 U.S. isolation methods market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 14 U.S. downstream analysis market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 15 U.S. exosomes market estimates & forecasts, by biomolecule type, 2014 - 2030 (USD Million)
TABLE 16 U.S. exosomes market estimates & forecasts, by application, 2014 - 2030 (USD Million)
TABLE 17 Canada exosomes market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 18 Canada isolation methods market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 19 Canada downstream analysis market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 20 Canada exosomes market estimates & forecasts, by biomolecule type, 2014 - 2030 (USD Million)
TABLE 21 Canada exosomes market estimates & forecasts, by application, 2014 - 2030 (USD Million)
TABLE 22 Europe exosomes market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 23 Europe isolation methods market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 24 Europe downstream analysis market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 25 Europe exosomes market estimates & forecasts, by biomolecule type, 2014 - 2030 (USD Million)
TABLE 26 Europe exosomes market estimates & forecasts, by application, 2014 - 2030 (USD Million)
TABLE 27 Germany exosomes market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 28 Germany isolation methods market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 29 Germany downstream analysis market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 30 Germany exosomes market estimates & forecasts, by biomolecule type, 2014 - 2030 (USD Million)
TABLE 31 Germany exosomes market estimates & forecasts, by application, 2014 - 2030 (USD Million)
TABLE 32 U.K. exosomes market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 33 U.K. isolation methods market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 34 U.K. downstream analysis market estimates & forecasts, by workflow, 2014 - 2030 (USD Million)
TABLE 35 U.K. exosomes market estimates & forecasts, by biomolecule type, 2014 - 2030 (USD Million)
TABLE 36 U.K. exosomes market estimates & forecasts, by application, 2014 - 2030 (USD Million)
TABLE 37 Asia Pacific exosomes market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 38 Asia Pacific isolation methods market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 39 Asia Pacific downstream analysis market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 40 Asia Pacific exosomes market estimates & forecasts, by biomolecule type, 2014 - 2030 (USD Thousand)
TABLE 41 Asia Pacific exosomes market estimates & forecasts, by application, 2014 - 2030 (USD Thousand)
TABLE 42 Japan exosomes market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 43 Japan isolation methods market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 44 Japan downstream analysis market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 45 Japan exosomes market estimates & forecasts, by biomolecule type, 2014 - 2030 (USD Thousand)
TABLE 46 Japan exosomes market estimates & forecasts, by application, 2014 - 2030 (USD Thousand)
TABLE 47 China exosomes market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 48 China isolation methods market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 49 China downstream analysis market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 50 China exosomes market estimates & forecasts, by biomolecule type, 2014 - 2030 (USD Thousand)
TABLE 51 China exosomes market estimates & forecasts, by application, 2014 - 2030 (USD Thousand)
TABLE 52 Latin America exosomes market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 53 Latin America isolation methods market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 54 Latin America downstream analysis market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 55 Latin America exosomes market estimates & forecasts, by biomolecule type, 2014 - 2030 (USD Thousand)
TABLE 56 Latin America exosomes market estimates & forecasts, by application, 2014 - 2030 (USD Thousand)
TABLE 57 Brazil exosomes market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 58 Brazil isolation methods market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 59 Brazil downstream analysis market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 60 Brazil exosomes market estimates & forecasts, by biomolecule type, 2014 - 2030 (USD Thousand)
TABLE 61 Brazil exosomes market estimates & forecasts, by application, 2014 - 2030 (USD Thousand)
TABLE 62 MEA exosomes market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 63 MEA isolation methods market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 64 MEA downstream analysis market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 65 MEA exosomes market estimates & forecasts, by biomolecule type, 2014 - 2030 (USD Thousand)
TABLE 66 MEA exosomes market estimates & forecasts, by application, 2014 - 2030 (USD Thousand)
TABLE 67 South Africa exosomes market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 68 South Africa isolation methods market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 69 South Africa downstream analysis market estimates & forecasts, by workflow, 2014 - 2030 (USD Thousand)
TABLE 70 South Africa exosomes market estimates & forecasts, by biomolecule type, 2014 - 2030 (USD Thousand)
TABLE 71 South Africa exosomes market estimates & forecasts, by application, 2014 - 2030 (USD Thousand)

List of Figures

FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping for biomolecule type, 2016
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter's Five Forces Analysis
FIG. 15 Exosomes market workflow outlook key takeaways
FIG. 16 Exosomes market: Workflow movement analysis
FIG. 17 Global isolation methods market, 2014 - 2030 (USD Million)
FIG. 18 Global ultracentrifugation market, 2014 - 2030 (USD Million)
FIG. 19 Global immunocapture on beads market, 2014 - 2030 (USD Million)
FIG. 20 Global precipitation market, 2014 - 2030 (USD Million)
FIG. 21 Global filtration market, 2014 - 2030 (USD Million)
FIG. 22 Global downstream analysis market, 2014 - 2030 (USD Million)
FIG. 23 Global cell surface marker analysis using flow cytometry market, 2014 - 2030 (USD Million)
FIG. 24 Global protein analysis using blotting & ELISA market, 2014 - 2030 (USD Million)
FIG. 25 Global RNA analysis with NGS & PCR market, 2014 - 2030 (USD Million)
FIG. 26 Global proteomic analysis using mass spectrometry market, 2014 - 2030 (USD Million)
FIG. 27 Global other methods market, 2014 - 2030 (USD Million)
FIG. 28 Exosomes market: Biomolecule type outlook key takeaways
FIG. 29 Global exosomes market: Biomolecule type movement analysis
FIG. 30 Global non-coding RNAs market, 2014 - 2030 (USD Million)
FIG. 31 Global mRNA (exoRNA) market, 2014 - 2030 (USD Million)
FIG. 32 Global proteins/peptides market, 2014 - 2030 (USD Million)
FIG. 33 Global DNA based targeted sequencing & resequencing market, 2014 - 2030 (USD Million)
FIG. 34 Global lipids market, 2014 - 2030 (USD Million)
FIG. 35 Exosomes market: Application outlook key takeaways
FIG. 36 Exosomes market: Application movement analysis
FIG. 37 Global cancer market, 2014 - 2030 (USD Million)
FIG. 38 Global neurodegenerative diseases market, 2014 - 2030 (USD Million)
FIG. 39 Global cardiovascular diseases market, 2014 - 2030 (USD Million)
FIG. 40 Global infectious diseases market, 2014 - 2030 (USD Million)
FIG. 41 Global others market, 2014 - 2030 (USD Million)
FIG. 42 Regional market place: Key takeaway
FIG. 43 Exosomes regional outlook, 2016 & 2030
FIG. 44 North America exosomes market, 2014 - 2030 (USD Million)
FIG. 45 U.S. exosomes market, 2014 - 2030 (USD Million)
FIG. 46 Canada exosomes market, 2014 - 2030 (USD Million)
FIG. 47 Europe exosomes market, 2014 - 2030 (USD Million)
FIG. 48 Germany exosomes market, 2014 - 2030 (USD Million)
FIG. 49 U.K. exosomes market, 2014 - 2030 (USD Million)
FIG. 50 Asia Pacific exosomes market, 2014 - 2030 (USD Thousand)
FIG. 51 Japan exosomes market, 2014 - 2030 (USD Thousand)
FIG. 52 China exosomes market, 2014 - 2030 (USD Thousand)
FIG. 53 Latin America exosomes market, 2014 - 2030 (USD Thousand)
FIG. 54 Brazil exosomes market, 2014 - 2030 (USD Thousand)
FIG. 55 Middle East & Africa exosomes market, 2014 - 2030 (USD Thousand)
FIG. 56 South Africa exosomes market, 2014 - 2030 (USD Thousand)
FIG. 57 Strategy framework
FIG. 58 Participant categorization